These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27113414)

  • 21. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis.
    Zhang Y; Pötter S; Chen CW; Liang R; Gelse K; Ludolph I; Horch RE; Distler O; Schett G; Distler JHW; Dees C
    Ann Rheum Dis; 2018 May; 77(5):744-751. PubMed ID: 29431122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
    Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA
    Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Mitochondrial Transcription Factor A Expression Promotes Mitochondrial Damage to Drive Fibroblast Activation and Fibrosis in Systemic Sclerosis.
    Zhou X; Trinh-Minh T; Tran-Manh C; Gießl A; Bergmann C; Györfi AH; Schett G; Distler JHW
    Arthritis Rheumatol; 2022 May; 74(5):871-881. PubMed ID: 34807516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
    Wei J; Ghosh AK; Chu H; Fang F; Hinchcliff ME; Wang J; Marangoni RG; Varga J
    Arthritis Rheumatol; 2015 May; 67(5):1323-34. PubMed ID: 25707573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition.
    Al-Hattab DS; Safi HA; Nagalingam RS; Bagchi RA; Stecy MT; Czubryt MP
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H658-H668. PubMed ID: 29906225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twist1 dimer selection regulates cranial suture patterning and fusion.
    Connerney J; Andreeva V; Leshem Y; Muentener C; Mercado MA; Spicer DB
    Dev Dyn; 2006 May; 235(5):1345-57. PubMed ID: 16502419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling.
    Bridges RS; Kass D; Loh K; Glackin C; Borczuk AC; Greenberg S
    Am J Pathol; 2009 Dec; 175(6):2351-61. PubMed ID: 19893041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twist1 is a key regulator of cancer-associated fibroblasts.
    Lee KW; Yeo SY; Sung CO; Kim SH
    Cancer Res; 2015 Jan; 75(1):73-85. PubMed ID: 25368021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis.
    Zhang Y; Shen L; Zhu H; Dreissigacker K; Distler D; Zhou X; Györfi AH; Bergmann C; Meng X; Dees C; Trinh-Minh T; Ludolph I; Horch R; Ramming A; Schett G; Distler JHW
    Ann Rheum Dis; 2020 Sep; 79(9):1227-1233. PubMed ID: 32482644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
    Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
    J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).
    Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H
    Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator.
    Bhattacharyya S; Wang W; Graham LV; Varga J
    Arthritis Res Ther; 2016 Oct; 18(1):216. PubMed ID: 27716397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis.
    Worrell JC; Leslie J; Smith GR; Zaki MYW; Paish HL; Knox A; James ML; Cartwright TN; O'Reilly S; Kania G; Distler O; Distler JHW; Herrick AL; Jeziorska M; Borthwick LA; Fisher AJ; Mann J; Mann DA; Oakley F
    Rheumatology (Oxford); 2020 Dec; 59(12):3939-3951. PubMed ID: 32725139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
    Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
    Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis.
    Dees C; Tomcik M; Palumbo-Zerr K; Distler A; Beyer C; Lang V; Horn A; Zerr P; Zwerina J; Gelse K; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2012 Sep; 64(9):3006-15. PubMed ID: 22549363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor Twist1 drives fibroblast activation to promote kidney fibrosis via signaling proteins Prrx1/TNC.
    Sun L; Liu L; Jiang J; Liu K; Zhu J; Wu L; Lu X; Huang Z; Yuan Y; Crowley SD; Mao H; Xing C; Ren J
    Kidney Int; 2024 Nov; 106(5):840-855. PubMed ID: 39181396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.
    Bhattacharyya S; Kelley K; Melichian DS; Tamaki Z; Fang F; Su Y; Feng G; Pope RM; Budinger GR; Mutlu GM; Lafyatis R; Radstake T; Feghali-Bostwick C; Varga J
    Am J Pathol; 2013 Jan; 182(1):192-205. PubMed ID: 23141927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.
    Bergmann C; Akhmetshina A; Dees C; Palumbo K; Zerr P; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2011 Dec; 70(12):2191-8. PubMed ID: 21873331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.